Canada Markets close in 3 mins

FSD Pharma Inc. (HUGE.CN)

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Add to watchlist
4.0000-0.0800 (-1.96%)
As of 3:25PM EDT. Market open.
Currency in CAD

Valuation Measures

Market Cap (intraday) 540.88M
Enterprise Value 321.91M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)171.33
Price/Book (mrq)0.66
Enterprise Value/Revenue 391.82
Enterprise Value/EBITDA 6-0.66

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-82.35%
S&P500 52-Week Change 3N/A
52 Week High 324.1206
52 Week Low 33.5100
50-Day Moving Average 35.0791
200-Day Moving Average 35.4830

Share Statistics

Avg Vol (3 month) 360.92k
Avg Vol (10 day) 3112.25k
Shares Outstanding 510.22M
Float 6.95M
% Held by Insiders 113.19%
% Held by Institutions 10.00%
Shares Short (Jul. 14, 2020) 487.74k
Short Ratio (Jul. 14, 2020) 44.42
Short % of Float (Jul. 14, 2020) 4N/A
Short % of Shares Outstanding (Jul. 14, 2020) 40.86%
Shares Short (prior month Jun. 14, 2020) 41.23M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:201
Last Split Date 3Oct. 15, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-16,130.07%

Management Effectiveness

Return on Assets (ttm)-38.95%
Return on Equity (ttm)-93.40%

Income Statement

Revenue (ttm)238.6k
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-3.33M
EBITDA -33.03M
Net Income Avi to Common (ttm)-52.67M
Diluted EPS (ttm)-7.3710
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.39M
Total Cash Per Share (mrq)1.64
Total Debt (mrq)2.01M
Total Debt/Equity (mrq)4.38
Current Ratio (mrq)4.83
Book Value Per Share (mrq)6.10

Cash Flow Statement

Operating Cash Flow (ttm)-19.36M
Levered Free Cash Flow (ttm)-15.77M